<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20190530043762N2</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2022-11-21</date_registration>
      <primary_sponsor>Shiraz University</primary_sponsor>
      <public_title>The effect of plyometric Training on the neuromuscular indicators of athletes</public_title>
      <acronym></acronym>
      <scientific_title>The effects of plyometric training with and without additional loads on neuromuscular index and performance in male youth’s soccer player</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-12-21</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>39</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/65814</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Randomization method: Simple randomization	
Random unit: Individual
Randomization Tool: Shuffle Cards
Random Sequence Construction Method: The sample selection method will be available in this study and randomly divided into Three distinct groups. Prior to the implementation of the research, 39 young male soccer player (15-17years old) were selected after completing the health questionnaire in physical activity and obtaining personal data. The names of the subjects are recorded on individual cards (each subject has a special card). Then all the cards are thrown in the sphere and are thrown well. After each flipping, a card is removed from the sphere and according to the flipping sequence, they are placed in the control group or intervention 1 or intervention 2. The sequence is that the first card removed is assigned to the control group, the second card removed to intervention 1, and the third card removed to intervention 2. This process is repeated until all the cards are removed from the sphere and assigned to the studied groups. Then completing and registering names in their groups, to hide the process of grouping the subject, through a letter packed with their status in the study and their group will inform the subject. In this letter, the groups are marked with the number and the full description of each group's actions is mentioned. For example, in the closed letter, the first card that out of the ball, are cited the person's activities during the intervention, and the number of his group (group 1), Blinding description: Subjects, instructors, and experts evaluating are kept blind in this study. In relation to the participant, each subject will be informed about the necessary details of their duties as well as their group number in a closed letter. The letter does not mention the group name and only the group number. However, in order to respect the ethics and rights of the subject, all of the tasks and actions that are to be performed are described. People in the control group will be coded with code 1, people in intervention group 1 with code 2, and people in intervention group 2 with code 3. The information about conducting tests and interventions for each group is fully explained and explained and interpreted in a separate meeting for each group. In addition, in order to perform the research plane, 3 coaches were assigned by a closed letter, while explaining all the training and safety issues for each group. Neuromuscular function tests are also performed by technicians and examiners who are fully aware of how to perform the tests. None of the examiners had any information about the intervention status of the subjects. Therefore, in this study, none of the instructors, subjects, and examiners have any information about the status of the subjects (which group is the intervention group and which one is the control group), although the tasks and all the tests and safety aspects will be describe for them.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Neuromuscular performance of soccer players.</hc_freetext>
      <i_freetext>Intervention 1: The intervention group of body weight plyometric training: for 8 weeks/ 2 sessions per week. Intervention 2: The intervention group of additional load plyometric training: for 8 weeks/ 2 sessions per week/ Applying additional load equal to 10% of body weight. Intervention 3: Control group: They will continue their usual football training routine in parallel with the intervention groups.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
All the data collected in the present study about the neuromuscular indicators as well as the individual characteristics of the participants can be shared with researchers.

When:
Start accessing the data immediately after the results are published

To whom:
Academic researchers

Conditions:
For the purpose of follow-up or meta-analysis studies

Where to obtain:
Shiraz University, Department of Sports Sciences, Dr. ‪Maryam koushkie Jahromi

How to obtain:
Sending the application and providing the necessary documents for employment in one of the reputable scientific centers to the email address Koushkie53@yahoo.com.A response will be sent one week after submitting the request. If agreed, the data will be sent to the researcher as an Excel file.

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>‪Maryam koushkie Jahromi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Sports Sciences, Shiraz University, Eram Square, Jomohri Blvd., Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194684334</zip>
        <telephone>+98 71 3613 4000</telephone>
        <email>Koushkie53@yahoo.com</email>
        <affiliation>Shiraz university</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>‪Maryam koushkie Jahromi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Sports Sciences, Shiraz University, Eram Square, Jomohri Blvd., Shiraz</address>
        <city>Shiraz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>7194684334</zip>
        <telephone>+98 71 3613 4000</telephone>
        <email>Koushkie53@yahoo.com</email>
        <affiliation>Shiraz university</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age range between 15 and 17 years old
Gender is male
Body mass index should be between 18-25
The sports field is Soccer (at least one year of experience participating in regional league matches)
No history of surgery due to sports and musculoskeletal injuries</inclusion_criteria>
      <agemin>15 years</agemin>
      <agemax>17 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>Ages less than 15 and more than 17 years
History of injuries leading to medical prohibition to participate in sports activities
Body mass index less than 18 and more than 25
Use of prohibited drugs and ergogenic substances in athletes
Lack of participation in official football matches
Lack of membership in official soccer clubs</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>The intervention group of body weight plyometric training: for 8 weeks/ 2 sessions per week</i_keyword>
      <i_keyword>The intervention group of additional load plyometric training: for 8 weeks/ 2 sessions per week/ Applying additional load equal to 10% of body weight</i_keyword>
      <i_keyword>Control group: They will continue their usual football training routine in parallel with the intervention groups</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Maximum isokinetic force and force development rate of knee extensor and flexor muscles. Timepoint: Before and after the intervention (Exercise training). Method of measurement: The maximum isokinetic force as well as the rate of force development will be measured using the Biodex isokinetic dynamometer when performing knee flexion and extension tasks.</prim_outcome>
      <prim_outcome>Neuromuscular efficiency. Timepoint: Before and after the intervention (Exercise training). Method of measurement: Using the surface electromyogram of the knee extensor and flexor muscles during the isometric maximum strength test of knee extension and flexion.</prim_outcome>
      <prim_outcome>Explosive power of lower body muscles. Timepoint: Before and after the intervention (Exercise training). Method of measurement: Using the Sargent vertical jump test on the Ergo-jump machine.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shiraz University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-13</approval_date>
        <contact_name>Shiraz University Biomedical Ethics Committee</contact_name>
        <contact_address>Shiraz University, Jomhouri Blvd, Shiraz Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-07-13</approval_date>
        <contact_name>Shiraz University Biomedical Ethics Committee</contact_name>
        <contact_address>Shiraz University, Jomhouri Blvd, Shiraz Shiraz Fars Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
